Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

High yield fabrication of multilayer polydimethylsiloxane [corrected] devices with freestanding micropillar arrays.

Gregory CW, Sellgren KL, Gilchrist KH, Grego S.

Biomicrofluidics. 2013 Oct 28;7(5):56503. doi: 10.1063/1.4827600. eCollection 2013. Erratum in: Biomicrofluidics. 2013 Dec 02;7(6):69902.

2.
3.

The Cole relaxation frequency as a parameter to identify cancer in breast tissue.

Gregory WD, Marx JJ, Gregory CW, Mikkelson WM, Tjoe JA, Shell J.

Med Phys. 2012 Jul;39(7):4167-74. doi: 10.1118/1.4725172.

PMID:
22830750
4.

Clinical trials assessing ototopical agents in the treatment of pain associated with acute otitis media in children.

Wood DN, Nakas N, Gregory CW.

Int J Pediatr Otorhinolaryngol. 2012 Sep;76(9):1229-35. doi: 10.1016/j.ijporl.2012.05.022. Epub 2012 Jun 25. Review.

PMID:
22739231
5.

Development of reagents and assays for the detection of pathogenic Burkholderia species.

Qazi O, Rani M, Gnanam AJ, Cullen TW, Stead CM, Kensing H, McCaul K, Ngugi S, Prior JL, Lipka A, Nagy JM, Gregory CW, Judy BM, Harding SV, Titball RW, Sidhu SS, Trent MS, Kitto GB, Torres A, Estes DM, Iverson B, Georgiou G, Brown KA.

Faraday Discuss. 2011;149:23-36; discussion 63-77.

6.

14-3-3{eta} Amplifies Androgen Receptor Actions in Prostate Cancer.

Titus MA, Tan JA, Gregory CW, Ford OH, Subramanian RR, Fu H, Wilson EM, Mohler JL, French FS.

Clin Cancer Res. 2009 Dec 15;15(24):7571-7581.

7.

Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer.

Ponguta LA, Gregory CW, French FS, Wilson EM.

J Biol Chem. 2008 Jul 25;283(30):20989-1001. doi: 10.1074/jbc.M802392200. Epub 2008 May 29.

8.

Correction of electrode polarization contributions to the dielectric properties of normal and cancerous breast tissues at audio/radiofrequencies.

Stoneman MR, Kosempa M, Gregory WD, Gregory CW, Marx JJ, Mikkelson W, Tjoe J, Raicu V.

Phys Med Biol. 2007 Nov 21;52(22):6589-604. Epub 2007 Oct 26.

PMID:
17975285
9.

Antigonadotropins: a novel strategy to halt Alzheimer's disease progression.

Gregory CW, Atwood CS, Smith MA, Bowen RL.

Curr Pharm Des. 2006;12(6):685-90. Review.

PMID:
16472158
10.

Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer.

Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S, Chen YH.

Hum Pathol. 2005 Oct;36(10):1037-48. Epub 2005 Sep 6.

PMID:
16226102
11.

Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.

Titus MA, Gregory CW, Ford OH 3rd, Schell MJ, Maygarden SJ, Mohler JL.

Clin Cancer Res. 2005 Jun 15;11(12):4365-71.

12.

Protein C inhibitor (plasminogen activator inhibitor-3) expression in the CWR22 prostate cancer xenograft.

Glasscock LN, Réhault SM, Gregory CW, Cooper ST, Jackson TP, Hoffman M, Church FC.

Exp Mol Pathol. 2005 Aug;79(1):23-32.

PMID:
15878512
13.

Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.

Liu Y, Majumder S, McCall W, Sartor CI, Mohler JL, Gregory CW, Earp HS, Whang YE.

Cancer Res. 2005 Apr 15;65(8):3404-9.

14.

Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.

Gregory CW, Whang YE, McCall W, Fei X, Liu Y, Ponguta LA, French FS, Wilson EM, Earp HS 3rd.

Clin Cancer Res. 2005 Mar 1;11(5):1704-12.

15.

Novel therapeutic strategies for Alzheimer's disease based on the forgotten reproductive hormones.

Gregory CW, Bowen RL.

Cell Mol Life Sci. 2005 Feb;62(3):313-9. Review.

PMID:
15723167
16.

Dementia and testosterone levels in men.

Bowen RL, Martins RN, Gregory CW, Smith MA, Atwood CS.

JAMA. 2005 Feb 2;293(5):551; author reply 552. No abstract available.

PMID:
15687304
17.

Sex hormones and ApoE4: beyond steroids.

Bowen RL, Gregory CW.

J Alzheimers Dis. 2004 Jun;6(3):229-30. No abstract available.

PMID:
15252936
19.

The novel Ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro.

McPherson RA, Conaway MC, Gregory CW, Yue W, Santen RJ.

Prostate. 2004 Mar 1;58(4):325-34.

PMID:
14968433
20.

The androgen axis in recurrent prostate cancer.

Mohler JL, Gregory CW, Ford OH 3rd, Kim D, Weaver CM, Petrusz P, Wilson EM, French FS.

Clin Cancer Res. 2004 Jan 15;10(2):440-8.

21.

Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.

Gregory CW, Fei X, Ponguta LA, He B, Bill HM, French FS, Wilson EM.

J Biol Chem. 2004 Feb 20;279(8):7119-30. Epub 2003 Dec 8.

22.

Androgen receptor gene amplification and protein expression in recurrent prostate cancer.

Ford OH 3rd, Gregory CW, Kim D, Smitherman AB, Mohler JL.

J Urol. 2003 Nov;170(5):1817-21.

PMID:
14532783
23.

Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells.

McJilton MA, Van Sikes C, Wescott GG, Wu D, Foreman TL, Gregory CW, Weidner DA, Harris Ford O, Morgan Lasater A, Mohler JL, Terrian DM.

Oncogene. 2003 Sep 11;22(39):7958-68.

PMID:
12970744
24.

Apoptosis levels increase after castration in the CWR22 human prostate cancer xenograft.

Smitherman AB, Gregory CW, Mohler JL.

Prostate. 2003 Sep 15;57(1):24-31.

PMID:
12886520
25.

Human epidermal receptor-2 expression in prostate cancer.

Calvo BF, Levine AM, Marcos M, Collins QF, Iacocca MV, Caskey LS, Gregory CW, Lin Y, Whang YE, Earp HS, Mohler JL.

Clin Cancer Res. 2003 Mar;9(3):1087-97.

26.
27.

Isolation and partial characterization of an epithelial cell line (RPE-F344) from the regenerating prostate of a normal adult male rat.

Presnell SC, Glover WJ, Borchert KM, Gregory CW, Mohler JL, Smith GJ.

Prostate Cancer Prostatic Dis. 1999 Dec;2(5/6):257-263.

28.

A novel method for the analysis of the androgen receptor.

Gaston KE, Ford III OH, Singh S, Gregory CW, Weyel DE, Smith GJ, Mohler JL.

Curr Urol Rep. 2002 Feb;3(1):67-74. Review.

PMID:
12084222
29.

Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium.

Gregory CW, Wilson EM, Apparao KB, Lininger RA, Meyer WR, Kowalik A, Fritz MA, Lessey BA.

J Clin Endocrinol Metab. 2002 Jun;87(6):2960-6.

PMID:
12050280
30.

Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer.

Mohler JL, Morris TL, Ford OH 3rd, Alvey RF, Sakamoto C, Gregory CW.

Prostate. 2002 Jun 1;51(4):247-55.

PMID:
11987153
31.

Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.

Wu D, Foreman TL, Gregory CW, McJilton MA, Wescott GG, Ford OH, Alvey RF, Mohler JL, Terrian DM.

Cancer Res. 2002 Apr 15;62(8):2423-9.

33.

The putative androgen receptor-A form results from in vitro proteolysis.

Gregory CW, He B, Wilson EM.

J Mol Endocrinol. 2001 Dec;27(3):309-19.

PMID:
11719283
34.

An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.

Chen C, Frierson HF Jr, Haggerty PF, Theodorescu D, Gregory CW, Dong JT.

Genomics. 2001 Oct;77(3):135-44.

PMID:
11597138
35.

Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.

Gregory CW, Johnson RT Jr, Presnell SC, Mohler JL, French FS.

J Androl. 2001 Jul-Aug;22(4):537-48.

36.

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.

Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS, Wilson EM.

Cancer Res. 2001 Jun 1;61(11):4315-9.

37.
38.

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

Gregory CW, Johnson RT Jr, Mohler JL, French FS, Wilson EM.

Cancer Res. 2001 Apr 1;61(7):2892-8.

39.

Immunohistochemical quantitation of androgen receptor expression using color video image analysis.

Kim D, Gregory CW, Smith GJ, Mohler JL.

Cytometry. 1999 Jan 1;35(1):2-10. Erratum in: Cytometry 1999 Apr 1;35(4):376.

40.

Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft.

Gregory CW, Kim D, Ye P, D'Ercole AJ, Pretlow TG, Mohler JL, French FS.

Endocrinology. 1999 May;140(5):2372-81.

PMID:
10218991
41.

Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes.

Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS.

Cancer Res. 1998 Dec 15;58(24):5718-24.

42.

Sodium nitroprusside/nitric oxide causes apoptosis in spiral ganglion cells.

Pai N, Zdanski CJ, Gregory CW, Prazma J, Carrasco V.

Otolaryngol Head Neck Surg. 1998 Oct;119(4):323-30.

PMID:
9781984
43.

Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma.

Presnell SC, Borchert KM, Glover WJ, Gregory CW, Mohler JL, Smith GJ.

Carcinogenesis. 1998 Apr;19(4):585-90.

PMID:
9600341
45.

Androgen-dependent protein interactions within an intron 1 regulatory region of the 20-kDa protein gene.

Avellar MC, Gregory CW, Power SG, French FS.

J Biol Chem. 1997 Jul 11;272(28):17623-31.

46.

Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.

Tan J, Sharief Y, Hamil KG, Gregory CW, Zang DY, Sar M, Gumerlock PH, deVere White RW, Pretlow TG, Harris SE, Wilson EM, Mohler JL, French FS.

Mol Endocrinol. 1997 Apr;11(4):450-9.

PMID:
9092797
47.

Expression of E-cadherin in immature rat and mouse testis and in rat Sertoli cell cultures.

Wu JC, Gregory CW, DePhilip RM.

Biol Reprod. 1993 Dec;49(6):1353-61.

PMID:
8286617
48.

P-cadherin and E-cadherin are co-expressed in MDCK cells.

Wu JC, Gregory CW, DePhilip RM.

Biochem Biophys Res Commun. 1993 Sep 30;195(3):1329-35.

PMID:
8216265
49.
50.

Malignant mesenchymoma obstructing the right ventricular outflow tract.

Ceretto WJ, Miller ML, Shea PM, Gregory CW, Vieweg WV.

Am Heart J. 1981 Jan;101(1):114-5. No abstract available.

PMID:
7457335

Supplemental Content

Loading ...
Support Center